StockData
BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30

Basel Medical Group Ltd

Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 18, 2025
$4.05+0.10 (+2.53%)

Close on Oct 19, 2026

Basel Medical statistics

Financials through Jun 30, 2025, price-based ratios appear once a share price is available

Valuation

Market Cap97.47M SGD
Enterprise Value102.46M SGD
PS Ratio8.61

Enterprise value

EV / Sales9.05

Income (trailing twelve months)

Revenue11.32M SGD
Pretax Income-11.05M SGD
Net Income-10.64M SGD
EPS (Diluted)-0.57 SGD

Margins

Pretax Margin-97.6%
Profit Margin-94.0%
FCF Margin-40.6%

Returns

Return on Assets (ROA)-56.9%

Growth

Revenue Growth (YoY)12.6%
Net Income Growth (YoY)-613.1%
EPS Growth (YoY)-538.5%
FCF Growth (YoY)-283.9%

Balance sheet

Cash & Short-Term Investments3.04M SGD
Total Debt8.03M SGD
Net Cash (Debt)-4.99M SGD
Net Cash Per Share-0.27 SGD
Working Capital3.13M SGD

Financial position

Current Ratio1.31
Quick Ratio1.23

Cash flow (trailing twelve months)

Operating Cash Flow-4.04M SGD
Capital Expenditures-556.94K SGD
Free Cash Flow-4.60M SGD
FCF Per Share-0.24 SGD

Efficiency

Asset Turnover0.61
Revenue Per Employee314.44K SGD
Profits Per Employee-295.44K SGD
Employee Count36

Dividends and yields

Earnings Yield-10.9%
FCF Yield-4.72%

Shares

Shares Outstanding18,785,800
Shares Change (YoY)15.6%
Float8,580,520
Shares Held by Insiders54.3%

Taxes

Income Tax-417.39K SGD

Scores

Altman Z-Score4.93
Piotroski F-Score2

Calculated by StockData from Basel Medical's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.